| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1655 | 2015 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 672 | 2015 |
| Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated JL Robinson, EB Lee, SX Xie, L Rennert, ER Suh, C Bredenberg, ... Brain 141 (7), 2181-2193, 2018 | 615 | 2018 |
| Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment PA Yushkevich, JB Pluta, H Wang, L Xie, SL Ding, EC Gertje, L Mancuso, ... Human brain mapping 36 (1), 258-287, 2015 | 609 | 2015 |
| Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging DR Roalf, PJ Moberg, SX Xie, DA Wolk, ST Moelter, SE Arnold Alzheimer's & dementia 9 (5), 529-537, 2013 | 467 | 2013 |
| Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan R Pomponio, G Erus, M Habes, J Doshi, D Srinivasan, E Mamourian, ... NeuroImage 208, 116450, 2020 | 421 | 2020 |
| Amyloid imaging in mild cognitive impairment subtypes DA Wolk, JC Price, JA Saxton, BE Snitz, JA James, OL Lopez, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 396 | 2009 |
| Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease OL Lopez, JT Becker, AS Wahed, J Saxton, RA Sweet, DA Wolk, W Klunk, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (6), 600-607, 2009 | 376 | 2009 |
| Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strengths BC Dickerson, E Fenstermacher, DH Salat, DA Wolk, RP Maguire, ... Neuroimage 39 (1), 10-18, 2008 | 335 | 2008 |
| Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease Y Chen, DA Wolk, JS Reddin, M Korczykowski, PM Martinez, ES Musiek, ... Neurology 77 (22), 1977-1985, 2011 | 334 | 2011 |
| A phase II study of fornix deep brain stimulation in mild Alzheimer’s disease AM Lozano, L Fosdick, MM Chakravarty, JM Leoutsakos, C Munro, E Oh, ... Journal of Alzheimer's Disease 54 (2), 777-787, 2016 | 332 | 2016 |
| Effects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study AM Koenig, D Mechanic-Hamilton, SX Xie, MF Combs, AR Cappola, L Xie, ... Alzheimer Disease & Associated Disorders 31 (2), 107-113, 2017 | 330 | 2017 |
| Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias M Yarchoan, SX Xie, MA Kling, JB Toledo, DA Wolk, EB Lee, ... Brain 135 (12), 3749-3756, 2012 | 324 | 2012 |
| The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition A Bakkour, JC Morris, DA Wolk, BC Dickerson Neuroimage 76, 332-344, 2013 | 309 | 2013 |
| MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults BC Dickerson, DA Wolk Neurology 78 (2), 84-90, 2012 | 283 | 2012 |
| Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 282 | 2010 |
| MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide VM Bashyam, G Erus, J Doshi, M Habes, IM Nasrallah, M Truelove-Hill, ... Brain 143 (7), 2312-2324, 2020 | 278 | 2020 |
| Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: an example of brain reserve AD Cohen, JC Price, LA Weissfeld, J James, BL Rosario, W Bi, RD Nebes, ... Journal of Neuroscience 29 (47), 14770-14778, 2009 | 278 | 2009 |
| Neurodegeneration across stages of cognitive decline in Parkinson disease D Weintraub, J Doshi, D Koka, C Davatzikos, AD Siderowf, JE Duda, ... Archives of neurology 68 (12), 1562-1568, 2011 | 268 | 2011 |
| Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders B Olsson, E Portelius, NC Cullen, Å Sandelius, H Zetterberg, ... JAMA neurology 76 (3), 318-325, 2019 | 235 | 2019 |
Paul YushkevichProfessor of Radiology, University of PennsylvaniaVerified email at mail.med.upenn.edu
